-
Vaccine Approval Important Step Forward Against Pandemic, Reminder of What's at Stake in Drug Pricing Debate
firstwordpharma
August 24, 2021
Pharmaceutical Research and Manufacturers of America President and CEO Stephen J. Ubl made the following statement after the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine.
-
US pharma lobby reaches out to patients and politicians with drug access campaign
pharmaceutical-technology
April 15, 2021
US industry association the Pharmaceutical Research and Manufacturers of America (PhRMA) has released a series of policies it says will make American healthcare more accessible and affordable.
-
Takeda President Becomes PhRMA Board Chair-Elect
americanpharmaceuticalreview
February 09, 2021
The Pharmaceutical Research and Manufacturers of America (PhRMA) elected two new officers to its board of directors. Ramona Sequeira, president of Takeda Pharmaceuticals USA, Inc. was named chair-elect. Sequeira formerly held the position of board ...
-
Biopharma industry commits to working with regulatory agencies on COVID-19 vaccines
europeanpharmaceuticalreview
January 15, 2021
A statement from biopharmaceutical industry groups has said they plan to work with regulatory agencies to gather data on COVID-19 vaccines.
-
US pharma initiates litigation challenging HHS and FDA action
europeanpharmaceuticalreview
November 26, 2020
PhRMA and other organisations have challenged action by the HHS and FDA that permits the importation of drugs from Canada without drug manufacturers’ oversight.
-
PhRMA announces new principles on clinical trial diversity
europeanpharmaceuticalreview
November 19, 2020
New principles on diversity in clinical trials in the US have been released to address systemic issues that deter people from participating in studies.
-
PhRMA Welcomes Genentech and Gilead Sciences to Association
americanpharmaceuticalreview
January 21, 2019
The Pharmaceutical Research and Manufacturers of America (PhRMA) announced Genentech, a member of the Roche Group, and Gilead Sciences have joined the association as members....
-
New group blames PBM's and hospitals for rising drug prices
pharmafile
November 20, 2018
A new group, organised under the banner of the Alliance to Protect Medical Innovation, is blaming hospitals and PBM’s for rising healthcare costs.
-
New hospital-led organisation aims to tackle drug pricing problem by manufacturing generic drugs
pharmafile
November 20, 2018
Seven organisations representing around 500 US hospitals have become the governing members of a newly established initiative aimed at reducing the price of drugs.
-
PhRMA blames hospitals for rising drug prices, hospitals association responds
pharmafile
September 13, 2018
The American pharmaceutical industry trade lobby PhRMA has suggested that hospitals are to blame for high drug prices as the furore around drug pricing continues in the United States of America...